LifeMine Therapeutics
MA - CambridgeBiotechnology
Focus: LifeMine Therapeutics is a Cambridge-based biotech founded in 2024 that develops therapeutics derived from fungi, representing an emerging platform approach to drug discovery. The company is early-stage and privately held, currently in Series C or later funding with no marketed products.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
SERIES C +
Open Jobs
0
About LifeMine Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow LifeMine Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
LIFE-001
Healthy VolunteersClinical Trials (1)
NCT06904807A Phase I Study to Evaluate LIFE-001
Phase 1Help build intelligence for LifeMine Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.